Oscar Health swings to $167.3 million Q3 profit and raises 2026 earnings outlook
Oscar Health reported third-quarter 2026 net income attributable to the company of $167.3 million, or $0.49 per diluted share, compared with a net loss of $137.5 million, or $(0.53) per diluted share, a year earlier. The company also raised its full-year 2026 earnings from operations outlook to $850 million to $950 million, up from $600 million to $800 million, which points to a stronger profit picture for shareholders.
Key points
- Third-quarter total revenue was $5.1 billion, compared with $3.0 billion in the third quarter of 2025, driven by rate increases and higher membership.
- Medical loss ratio was 84.0% for the quarter, compared with 88.5% a year earlier; earnings from operations were $178.0 million, compared with a loss of $129.3 million.
- Third-quarter revenue included a $250 million benefit from updated risk adjustment estimates.
- Full-year 2026 total revenue outlook was raised to $19.0 billion to $19.3 billion, from $18.7 billion to $19.0 billion.
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.